Margit Bistrup Fischer

Margit Bistrup Fischer

Auto-generated profile, based on publicly available information

Margit Bistrup Fischer

Department of Growth and Reproduction, Copenhagen University Hospital—Rigshospitalet , Copenhagen

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2022 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
MLMarie L Ljubicic
Marie L Ljubicic
ABAlexander S Busch
Alexander S Busch
EUEmmie N Upners
Emmie N Upners
MFMargit B Fischer
Margit B Fischer
JPJørgen H Petersen
Jørgen H Petersen
CHCasper P Hagen
Casper P Hagen
Context: Minipuberty, a period of a transient activation of the hypothalamic-pituitary-gonadal (HPG) axis in both sexes, enables evaluation of gonadal function in infants suspected of hypogonadism. However, female minipuberty remains poorly elucidated. Objective: We aimed to establish continuous reference ranges for the most commonly used reproductive hormones and to evaluate the dynamics of the HPG axis in females aged 0 to 1 year. Design: The COPENHAGEN Minipuberty Study (ClinicalTrials.gov ID: NCT02784184), a longitudinal, prospective cohort study. Setting: Healthy infants from Copenhagen. Patients or Other Participants: A total of 98 healthy, term female infants followed with 6 examinations including venipuncture during the first year of life. Intervention(s): None. Main Outcome Measure(s): Serum concentrations of LH, FSH, inhibin B, anti-Müllerian hormone (AMH), estrone (E1), estradiol (E2), and SHBG were quantified using highly sensitive methods in 266 serum samples. Results: Reference ranges were established for LH, FSH, inhibin B, AMH, E1, E2, and SHBG. Two peaks were observed in normalized mean curves for all hormones. The first peaks were timed around postnatal days 15 to 27 followed by a general nadir for all hormones around days 58 to 92. The second peaks occurred around days 107 to 125 for inhibin B, AMH, E1, E2, and SHBG and days 164 to 165 for LH and FSH. Conclusions: We present age-related, continuous reference ranges of the most commonly used reproductive hormones and present novel data revealing a biphasic and prolonged female minipuberty. ClinicalTrials.gov ID: NCT02784184

1 September 2020 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
MFMargit Bistrup Fischer
Margit Bistrup Fischer
MLMarie Lindhardt Ljubicic
Marie Lindhardt Ljubicic
CHCasper P Hagen
Casper P Hagen
ATAjay Thankamony
Ajay Thankamony
KOKen Ong
Ken Ong
AJAnders Juul
Anders Juul
Context The use of anogenital distance (AGD) in clinical and epidemiological settings is increasing; however, sex-specific reference data on AGD and data on longitudinal changes in AGD in children is scarce. Objective To create age-, sex-, and method-related reference ranges of AGD in healthy boys and girls aged 0–24 months, to assess the age-related changes in AGD and to evaluate the 2 predominantly used methods of AGD measurement. Design The International AGD consortium comprising 4 centers compiled data from 1 cross-sectional and 3 longitudinal cohort studies (clinicaltrials.gov [NCT02497209]). Setting All data were collected from population-based studies, recruiting from 4 maternity or obstetric centers (United States, Cambridge [United Kingdom], Odense, and Copenhagen [Denmark]). Subjects This study included a total of 3705 healthy, mainly Caucasian children aged 0–24 months on whom 7295 measurements were recorded. Main Outcome Measures AGDAS (ano-scrotal), AGDAF (ano-fourchette), AGDAP (ano-penile), AGDAC (ano-clitoral), AGD body size indices (weight, body mass index [BMI], body surface area, and length), and intra- and interobserver biases. Results We created age-specific reference ranges by centers. We found that AGD increased from birth to 6 months of age and thereafter reached a plateau. Changes in AGD/BMI during the first year of life were minor (0–6% and 0–11% in boys and girls, respectively). Conclusions Reference ranges for AGD can be used in future epidemiological research and may be utilized clinically to evaluate prenatal androgen action in differences-in-sex-development patients. The increase in AGD during the first year of life was age-related, while AGD/BMI was fairly stable. The TIDES and Cambridge methods were equally reproducible.

1 May 2020 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
MFMargit B. Fischer
Margit B. Fischer
MVMarianne Vestgaard
Marianne Vestgaard
BÁBjörg Ásbjörnsdóttir
Björg Ásbjörnsdóttir
EMElisabeth Mathiesen
Elisabeth Mathiesen
PDPeter Damme
Peter Damme

27 September 2024 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
MFMargit Bistrup Fischer
Margit Bistrup Fischer
GMGylli Mola
Gylli Mola
ARAne Lilleøre Rom
Ane Lilleøre Rom
HFHanne Frederiksen
Hanne Frederiksen
TJTrine Holm Johannsen
Trine Holm Johannsen
CHCasper P Hagen
Casper P Hagen
Context: Female minipuberty is characterized by complex dynamics of circulating reproductive hormones, while the relationship between ovarian and uterine morphology and reproductive hormones remains to be elucidated. Objective: This work aimed to investigate the association between reproductive hormones and ovarian as well as uterine morphology by transabdominal ultrasound scan (TAUS) at minipuberty. Methods: A secondary analysis was conducted from The Copenhagen Analgesic Study (COPANA) (ClinicalTrials.gov NCT04369222) of healthy infant girls (n = 302, aged 3.4 months [0.4] mean [±SD]: mamma tissue diameter [mm], n = 300). TAUS: uterine volume (n = 230), endometrial thickness (n = 255), ovarian volume, antral follicle count (total/2-4 mm/≥5 mm) (n = 203). Blood samples (n = 269/302 = 89%): antimüllerian hormone (AMH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), inhibin B (immunoassays), progesterone (PROG), androstenedione (Adione), testosterone (T), estrone (E1), estradiol (E2) (liquid chromatography–tandem mass spectrometry). Statistics: Pearson/Spearman correlation coefficient (parametric/nonparametric data). Results: Total follicle count correlated positively with ovarian volume (r = 0.606; P < .001), AMH (r = 0.378; P < .001), inhibin B (r = 0.251; P < .001), and negatively with FSH concentrations (r = −0.327; P < .001). Larger follicles (≥5 mm) correlated positively with AMH (r = 0.264; P < .001), inhibin B (r = 0.230; P = .002), E1 (r = 0.209; P = .004), E2 (r = 0.269; P < .001), PROG (r = 0.160; P = .031), and T (r = 0.210; P = .004) and negatively with FSH (r = −0.183; P = .015). Circulating E1 and E2 levels correlated with the size of estrogen-responsive tissue sizes: E2 vs uterine volume (r = 0.134; P = .054), E2 vs endometrial thickness (r = 0.155; P = .020), E1 and E2 vs mammary tissue diameter (r = 0.213 and r = 0.198, respectively; both P < .001). Conclusion: Correlations between reproductive hormones and the number of antral follicles suggest that negative feedback in the female hypothalamic-pituitary-gonadal axis is established during minipuberty, with ovarian activity promoting uterine and glandular breast tissue growth. We provide normative data of infant ovarian and uterine morphology directly implementable to a clinical setting.

26 June 2024 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
ABAnna Borelli-Kjær
Anna Borelli-Kjær
LALise Aksglaede
Lise Aksglaede
RJRikke Beck Jensen
Rikke Beck Jensen
CHCasper Petri Hagen
Casper Petri Hagen
MLMarie Lindhardt Ljubicic
Marie Lindhardt Ljubicic
TJTrine Holm Johannsen
Trine Holm Johannsen
Objective: To describe the natural history of inhibin B throughout life according to sex, age, and pubertal development. Methods: Based on serum samples from 2707 healthy controls aged 0 to 80 years, sex- and age-specific reference ranges of inhibin B concentrations were constructed. Concentrations were evaluated according to pubertal development and use of oral contraceptives (OCs). Also, measurements from 42 patients with Klinefelter syndrome were included. Results: In both sexes, inhibin B concentrations were high during minipuberty, decreased in childhood, and significantly increased from Tanner stages B1 to B3 (peak: B4) in females and from G1 to G3 (peak: G3) in males. Despite variations in menstruating females, inhibin B concentrations remained relatively constant after puberty until becoming unmeasurable at menopause. Despite a modest decrease, the inhibin B concentration in males remained relatively high from puberty onward. At any age, males had highest concentrations. Inhibin B SD scores were lower in OC users (median SD score = −0.88) than in nonusers (SD score = 0.35), P < .001. In patients with Klinefelter syndrome, inhibin B concentrations spanned the reference range until approximately 15 years of age, where they decreased to subnormal or unmeasurable levels. Conclusion: Valuable sex- and age-specific reference data for inhibin B concentrations were provided. In OC users, decreased concentrations of inhibin B underlined the ovaries as the only place of inhibin B production. In patients with Klinefelter syndrome, the decline in inhibin B concentrations at puberty underlined the shift in regulation of inhibin B production at pubertal onset.

3 September 2021 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
EUEmmie N Upners
Emmie N Upners
MLMarie Lindhardt Ljubicic
Marie Lindhardt Ljubicic
ABAlexander S Busch
Alexander S Busch
MFMargit Bistrup Fischer
Margit Bistrup Fischer
Kristian AlmstrupKristian Almstrup
Kristian Almstrup
AJAnders Juul
Anders Juul
Context IGF-I is important for postnatal growth and may be of diagnostic value in infants suspected of pituitary disease; however, little is known about the impact of IGF-I and its determinants on infant growth. Importantly, detailed reference ranges for IGF-I and IGF binding protein-3 (IGFBP-3) concentrations during infancy are lacking. Objective To evaluate the rapid changes in weight and length as well as their determinants in healthy infants, and to establish age- and sex-specific reference curves for IGF-I and IGFBP-3 in children aged 0 to 1 years. Design Prospective longitudinal study. Setting Cohort study. Participants A total of 233 healthy children (114 girls) with repeated blood samples during the first year of life. Main Outcome Measure(s) Serum concentrations of IGF-I and IGFBP-3, length velocity, weight velocity, and PAPPA2 (rs1325598) genotype. Results Individual trajectories of length and weight velocities were sex specific. We provide detailed reference curves based on longitudinal data for IGF-I and IGFBP-3 during infancy. In both girls and boys, IGF-I decreased during infancy, whereas IGFBP-3 remained stable. IGF-I and IGFBP-3, but not PAPPA2 genotype, were positively associated with weight gain, but not with longitudinal growth. When stratified by sex, the association between weight gain and IGF-I only remained significant in girls. Conclusions Interestingly, we found a significant association between IGF-I and infant weight gain in girls, but not with longitudinal growth in the first year of life. Our findings highlight the role of IGF-I as an important anabolic hormone that is not limited to linear growth.